Jorge G. Quintero
Publications by Year
Research Areas
Cytokine Signaling Pathways and Interactions, Hepatitis C virus research, Rheumatoid Arthritis Research and Therapies, Hepatitis B Virus Studies, Clostridium difficile and Clostridium perfringens research
Most-Cited Works
- → Selective functional inhibition of JAK‐3 is sufficient for efficacy in collagen‐induced arthritis in mice(2010)74 cited
- → Small molecule antagonists of the bradykinin B1 receptor(1999)29 cited
- → 2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitors(2009)18 cited
- → Identification and initial optimization of inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB)(2018)9 cited
- → Synthesis and SAR studies of novel benzodiazepinedione-based inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB)(2018)9 cited
- → Design, synthesis, and structure-activity relationship of a bicyclic HBV capsid assembly modulator chemotype leading to the identification of clinical candidate AB-506(2023)6 cited
- → Preclinical anti-tumor activity of small-molecule oral PD-L1 checkpoint inhibitors.(2022)2 cited
- → Preclinical activity of small-molecule oral PD-L1 checkpoint inhibitors capable of reinvigorating T cell responses from chronic hepatitis B patients(2022)1 cited
- → The novel and selective JAK3 inhibitor WYE-152038 is highly efficacious in a mouse model of rheumatoid arthritis(2009)